Why is prenatal substance use screening important?

• A. To punish mothers who use substances
• B. To generate research data only
• C. To protect fetal and maternal health and provide early intervention, while addressing consent and stigma concerns
• D. To satisfy insurance requirements

Answer: (C)

Screening for substance use during pregnancy is about protecting both the mother and the baby by identifying any use early and then connecting the person with appropriate support before problems arise. When done as part of routine prenatal care, screening opens the door to timely counseling, medical management, and referrals to treatment or social services, which can reduce risks such as preterm birth, low birth weight, fetal growth issues, maternal overdose, and complications that might affect delivery and the newborn. It also supports coordination of care between obstetric providers, addiction specialists, and community resources to plan for a safer pregnancy and postpartum support.

Crucially, this work is carried out with the patient’s informed consent and in a nonjudgmental, confidential way. Addressing consent and stigma is essential because a respectful, private, and supportive approach builds trust, encourages honest disclosure, and increases the likelihood that a person will engage in treatment and other health resources. The aim is not punishment but health and safety—for both the mother and fetus—through early intervention and compassionate care.